Literature DB >> 27157693

Functionally Enhanced Human Stem Cell Derived Hepatocytes in Galactosylated Cellulosic Sponges for Hepatotoxicity Testing.

Farah Tasnim1, Yi-Chin Toh1, Yinghua Qu1, Huan Li1, Derek Phan1, Balakrishnan C Narmada1, Abhishek Ananthanarayanan1, Nikhil Mittal1, Ryan Q Meng2, Hanry Yu1,3,4,5,6,7.   

Abstract

Pluripotent stem cell derived hepatocyte-like cells (hPSC-HLCs) are an attractive alternative to primary human hepatocytes (PHHs) used in applications ranging from therapeutics to drug safety testing studies. It would be critical to improve and maintain mature hepatocyte functions of the hPSC-HLCs, especially for long-term studies. If 3D culture systems were to be used for such purposes, it would be important that the system can support formation and maintenance of optimal-sized spheroids for long periods of time, and can also be directly deployed in liver drug testing assays. We report the use of 3-dimensional (3D) cellulosic scaffold system for the culture of hPSC-HLCs. The scaffold has a macroporous network which helps to control the formation and maintenance of the spheroids for weeks. Our results show that culturing hPSC-HLCs in 3D cellulosic scaffolds increases functionality, as demonstrated by improved urea production and hepatic marker expression. In addition, hPSC-HLCs in the scaffolds exhibit a more mature phenotype, as shown by enhanced cytochrome P450 activity and induction. This enables the system to show a higher sensitivity to hepatotoxicants and a higher degree of similarity to PHHs when compared to conventional 2D systems. These results suggest that 3D cellulosic scaffolds are ideal for the long-term cultures needed to mature hPSC-HLCs. The mature hPSC-HLCs with improved cellular function can be continually maintained in the scaffolds and directly used for hepatotoxicity assays, making this system highly attractive for drug testing applications.

Entities:  

Keywords:  hepatocytes; hepatotoxicity; scaffolds; stem cells

Mesh:

Substances:

Year:  2016        PMID: 27157693     DOI: 10.1021/acs.molpharmaceut.6b00119

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  19 in total

1.  Advances in Engineered Human Liver Platforms for Drug Metabolism Studies.

Authors:  Gregory H Underhill; Salman R Khetani
Journal:  Drug Metab Dispos       Date:  2018-08-22       Impact factor: 3.922

Review 2.  Microfabrication of liver and heart tissues for drug development.

Authors:  Grace E Brown; Salman R Khetani
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-07-05       Impact factor: 6.237

Review 3.  Human liver model systems in a dish.

Authors:  Wendy L Thompson; Takanori Takebe
Journal:  Dev Growth Differ       Date:  2021-02-02       Impact factor: 2.053

Review 4.  Advances in Engineered Liver Models for Investigating Drug-Induced Liver Injury.

Authors:  Christine Lin; Salman R Khetani
Journal:  Biomed Res Int       Date:  2016-09-20       Impact factor: 3.411

Review 5.  Translational Prospects and Challenges in Human Induced Pluripotent Stem Cell Research in Drug Discovery.

Authors:  Masaki Hosoya; Katherine Czysz
Journal:  Cells       Date:  2016-12-21       Impact factor: 6.600

6.  Directed Differentiation of Adult Liver Derived Mesenchymal Like Stem Cells into Functional Hepatocytes.

Authors:  Xiaobei Luo; Kapish Gupta; Abhishek Ananthanarayanan; Zenan Wang; Lei Xia; Aimin Li; Rashidah Binte Sakban; Side Liu; Hanry Yu
Journal:  Sci Rep       Date:  2018-02-12       Impact factor: 4.379

7.  Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell-Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury.

Authors:  Catherine C Bell; Volker M Lauschke; Sabine U Vorrink; Henrik Palmgren; Rodger Duffin; Tommy B Andersson; Magnus Ingelman-Sundberg
Journal:  Drug Metab Dispos       Date:  2017-01-30       Impact factor: 3.922

Review 8.  Bioengineered Liver Models for Drug Testing and Cell Differentiation Studies.

Authors:  Gregory H Underhill; Salman R Khetani
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-12-06

9.  Ubx dynamically regulates Dpp signaling by repressing Dad expression during copper cell regeneration in the adult Drosophila midgut.

Authors:  Hongjie Li; Yanyan Qi; Heinrich Jasper
Journal:  Dev Biol       Date:  2016-08-25       Impact factor: 3.582

Review 10.  Pluripotent Stem Cell-Derived Human Tissue: Platforms to Evaluate Drug Metabolism and Safety.

Authors:  Jose Meseguer-Ripolles; Salman R Khetani; Javier G Blanco; Mairi Iredale; David C Hay
Journal:  AAPS J       Date:  2017-12-21       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.